← Leaderboards
Vickie Coleman
Leidos Biomedical Research, Inc.
$6,457,269
Attributed
$6,457,269
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$6,457,269 · 1
By mechanism
N01$6,457,269 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Ethan Dmitrovsky$597,515,186
- Lynn Briscoe$495,968,635
- Leonard Freedmand$281,097,701
Others in their field
Other Emerging Leaders on “Agonist”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Aaron Esser-Kahn · University Of Chicago$13,378,548
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Xinhua Li · Nano Terra, Inc.$11,941,250
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
AgonistAntibodiesCanis FamiliarisCompanionsDivision Of Cancer Treatment And DiagnosisImmunotherapyProductionTargeted Agent